Essex Property Trust, Inc. vs Kenvue Inc. Common Stock — how do they compare? Essex Property Trust, Inc. trades at $271.57 (market cap $17.26B), while Kenvue Inc. Common Stock trades at $17.68 (market cap $34.06B). The key difference: Kenvue Inc. Common Stock is the larger of the two by market cap, and Kenvue Inc. Common Stock pays the higher dividend (4.74%). Which is the better fit depends on your goals.
| ESS | KVUE | |
|---|---|---|
Market Cap | $17.26B | $34.06B |
Volume | 454,464 | 23,267,228 |
Sector | Real Estate | Consumer Staples |
52-Week High | $298.33 | $19.83 |
52-Week Low | $239.61 | $14.11 |
Typical Hold Time | 111 Days | — |
Enterprise Value | $23.86B | $41.56B |
Dividend Yield | 3.86% | 4.74% |
Signals from Pluang's Aura AI — not financial advice
ESS trades at $271.57, up 1.31% with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported strong Q2 2026 results beating FFO guidance and raised full-year outlook, while resolving major litigation. Fundamentals show solid revenue growth to $1.89B in 2025 with 21.48% net margins, though valuation multiples remain elevated with P/E of 41.83.
Outlook remains cautiously optimistic with analyst consensus target of $303.41 offering 12% upside potential. Key opportunities include sustained West Coast multifamily demand and operational efficiency, while risks involve elevated debt levels and potential regional economic headwinds affecting rental markets.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Essex Property Trust owns a portfolio of 253 apartment communities with over 62,000 units and is developing three additional properties with 571 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.
Read more on ESS →Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →